| Patents for C07J 9 - Normal steroids containing carbon, hydrogen, halogen, or oxygen, substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane (4,897) |
|---|
| 03/26/2003 | CN1405175A C60 glucocorticoid and it use |
| 03/25/2003 | US6538037 Inhibiting the hyperproliferation of malignant or neoplastic cells by treating the cells with an antiproliferative amount of 1 alpha ,24(S)-dihydroxyvitamin D2 the cells being cancers of the lung, neck and head, pancreas, endometrium, bladder |
| 03/20/2003 | WO2003023047A1 7α-hydroxypregn-4-en-3-one-20-carbaldehyde, process for producing the same, and process for producing 7α,21-dihydroxy-20-methylpregn-4-en-3-one from the same |
| 03/20/2003 | WO2003022866A1 LIGAND FOR ß2-GLYCOPROTEIN I AND USE THEREOF |
| 03/20/2003 | WO2003022865A1 Process for the isolation of sterols and/or wax alcohols from tall oil products |
| 03/20/2003 | US20030055029 Combbretastatin a-4 as an anti-angiogenic agent |
| 03/19/2003 | CN1403469A Antineoplastic compound and its prepn and medicinal use |
| 03/13/2003 | WO2003020860A2 Methods for treating deodorizer distillate |
| 03/13/2003 | WO2003020214A2 Bile-acid derived compounds for enhancing oral absorption and systemic bioavailability of drugs |
| 03/13/2003 | WO2002053519A3 Hydrophobic polyamine analogs and methods for their use |
| 03/13/2003 | WO2002042319A3 2-substituted estrogens as antiangiogenic agents |
| 03/12/2003 | EP1291355A1 Process for the isolation of sterols and/or wax alcohols from tall oil products |
| 03/12/2003 | EP1289507A1 Use of an aldosterone antagonist for the treatment or prohpylaxis of aldosterone-mediated pathogenic effects |
| 03/12/2003 | CN1402734A 3-methylene steroid deriv. |
| 03/05/2003 | EP1287017A1 2-substituted pregna-1,3,5(10)-triene and chola-1,3,5(10)-triene derivatives and their biological activity |
| 03/05/2003 | EP1192175B1 Method of treating organic substances |
| 03/04/2003 | US6528676 Estrogenic compounds as anti-mitotic agents |
| 03/04/2003 | US6528501 Control of fertility |
| 02/26/2003 | CN1398589A Medicinal use and prepn process of general ketosteroid of Tinospora Hainanesis |
| 02/20/2003 | WO2003013546A1 Hypoglycemic agent |
| 02/20/2003 | CA2456030A1 Hypoglycemic agent |
| 02/18/2003 | USRE37999 Method of suppressing atherogenesis in a human patient, comprising administering to the patient an amount of a cholesterol 20hydroperoxide selected from the group consisting of 20(R)-hydroperoxy 25-hydroxycholesterol, |
| 02/13/2003 | US20030032824 Meiosis regulating compounds |
| 02/12/2003 | EP1023314B1 Bile acid salts of metals with physiological action and the use thereof in therapy |
| 02/12/2003 | EP0614463B1 Angiostatic steroids |
| 02/12/2003 | CN1396908A Palatable arginine compounds and uses thereof for cardiovascular health |
| 02/12/2003 | CN1101401C Stereo-selective synthesizing method for ursodesoxycholic acid |
| 02/11/2003 | US6518262 22R-hydroxycholesta-8, 14-diene derivatives for the inhibition of meiosis |
| 02/06/2003 | WO2003010182A1 Novel dammarane sapogenins, their use as anti-cancer agents, and a process for producing same |
| 02/05/2003 | EP1280816A1 19-norbufalin derivatives, their preparation and pharmaceutical compositions containing them |
| 01/23/2003 | WO2003007323A2 Method for preparing organic, in particular lithocholic acid, nanotubes and uses thereof |
| 01/23/2003 | US20030018206 Crystals of a vitamin D derivative and a method for the preparation thereof |
| 01/23/2003 | CA2453427A1 Method for preparing organic, in particular lithocholic acid, nanotubes and uses thereof |
| 01/22/2003 | EP1277760A1 Method of searching for arteriosclerosis inhibitors and shrinkers |
| 01/21/2003 | US6509032 Nontoxic biodegradable derivative of cholesterol having carbamate, ester or amide linker, spacer and primary, tertiary or quaternized amino groups; transfection of nucleic acids into cells |
| 01/20/2003 | WO2002020552A1 Process for the preparation of pregnane derivatives |
| 01/20/2003 | CA2416850A1 Process for the preparation of pregnane derivatives |
| 01/16/2003 | US20030012813 Cationic lipid with a lipophilic group derived from cholesterol; an amide or carbamate linker bond; an alkylene spacer arm; and a cationic primary, secondary, tertiary or quaternary amino group. facilitating nucleic acid transfer |
| 01/15/2003 | EP1274718A1 A process for the preparation of 7.alpha.-hydroxy 3-aminosubstituted sterols using intermediates with an unprotected 7.alpha.-hydroxy group |
| 01/09/2003 | WO2003002110A1 METHODS FOR PREPARATION AND USE OF 1α,24(S)-DIHYDROXYVITAMIN D¿2? |
| 01/09/2003 | WO2002072084A8 Glycyrrhetinic acid derivatives, progesterone and progesterone derivatives and their use for the manufacture of a medicament to inhibit 11beta-hydroxysteroid dehydrogenase activity |
| 01/09/2003 | CA2451039A1 Methods for preparation and use of 1.alpha.,24(s)-dihydroxyvitamin d2 |
| 01/08/2003 | CN1098273C High-stereoselectivity synthesization of 24R, 25- and 24S, 25-dihydroxysteroid |
| 01/03/2003 | WO2003000075A1 Method for manufacturing of free-flowing powder containing water-dispersible sterols |
| 01/03/2003 | CA2451146A1 Method for manufacturing of free-flowing powder containing water-dispersible sterols |
| 01/02/2003 | US20030004361 Process for the preparation of stanol esters |
| 01/02/2003 | US20030004148 Regulation of meiosis |
| 01/02/2003 | US20030003131 Method for manufacture of free-flowing powder containing water-dispersible sterols |
| 01/02/2003 | EP1268511A1 Process for producing diels-alder adducts of sterol 5,7-dienes using unsaturated fatty acid catalyst |
| 01/02/2003 | EP1268425A2 Carbamate caspase inhibitors and uses thereof |
| 01/02/2003 | EP1267900A1 Emulsion containing a plant extract, method for producing said emulsion and for obtaining a plant extract |
| 01/02/2003 | EP1267898A2 Bile acid containing prodrugs with enhanced bioavailability |
| 01/02/2003 | EP0754457B1 Antiobestic agent |
| 12/27/2002 | WO2002056874A3 Lipid-based nitric oxide donors |
| 12/26/2002 | US20020198141 Molecular conjugates for use in treatment of cancer |
| 12/24/2002 | US6497987 Photosensitive lithocholate derivative and chemically amplified photoresist composition containing the same |
| 12/19/2002 | US20020193357 Liver X receptor agonists |
| 12/19/2002 | US20020192306 Gastric acid secretion |
| 12/18/2002 | EP1265911A2 17-alpha-substituted-11-beta-substituted-4-aryl and 21-substituted 19-norpregnadienedione as antiprogestational agents |
| 12/18/2002 | EP1265606A1 Cell adhesion inhibitors |
| 12/12/2002 | US20020187971 Hybrid cholinergic agents and compositions, methods of making, and methods of using to treat a cholinergic disorder |
| 12/11/2002 | EP1163258B1 22r-hydroxycholesta-8,14-diene derivatives for the inhibition of meiosis |
| 12/11/2002 | CN1384811A Fluorination in liquid or supercritical carbon dioxide |
| 12/10/2002 | US6492538 Method of manufacturing a sterol ester mixture |
| 12/10/2002 | US6492536 Glucocorticoids; antiimflammatory and immunosuppressive agents |
| 12/05/2002 | US20020183531 Providing lithocholic acid by catalytic hydrogenation of ethyl-3-oxo-4,22-choladienate to give ethyl-3-oxocholanate, hydrolysis of C-24 ester, reduction of 3-keto group, hydrolysis of c-24 ester |
| 12/05/2002 | US20020183530 Method for purifying phytosterol concentrates using a pressurized fluid (carbon dioxide) |
| 12/05/2002 | US20020183295 For therapy of psychotic disorders, pain, sleep disorders, depression, Alzheimer's disease, tardive dyskinesia, Picks disease, Huntington's chorea, Frederic's ataxia, Gilles de la Pteriidae's disease, Down's Syndrome |
| 12/05/2002 | US20020183294 Therapy and prophylaxis of cognitive dysfunction in a human or non-human animal by administering sapogenin derivatives wherein the E and/or F ring of the fused ring system has been cleaved |
| 12/05/2002 | US20020183283 Meiosis regulating compounds |
| 12/05/2002 | US20020182232 Naphthofurandione dyes |
| 12/04/2002 | EP1261620A2 Cationic amphiphiles for use in nucleic acid transfection |
| 12/04/2002 | EP0984980B1 20-aralkyl-5alpha-pregnane derivatives |
| 12/04/2002 | EP0917534B1 6,7-oxygenated steroids and uses related thereto |
| 12/03/2002 | US6488967 Gastric acid secretion |
| 12/03/2002 | US6488960 Corticosteroid formulation |
| 11/28/2002 | WO2002094769A1 Solid reagent for sampling and derivatization of carbonyl compounds |
| 11/28/2002 | US20020177622 Neuroprotectants; enhancing cognition |
| 11/26/2002 | US6486148 Sensitize bacteria to other antibiotics; include at least two groups selected from (protected)aminoalkoxy(carbonyl), aminoalkylaminocarbonyl, aminoalkylcarbonylamino, azidoalkoxy, guanidinoalkoxy(carbonyl), and cyanoalkoxy |
| 11/26/2002 | US6486145 Meiosis regulating compounds |
| 11/21/2002 | WO2002092547A1 Method for producing ketones from carboxylic acid anhydrides |
| 11/21/2002 | WO2002072084A3 Glycyrrhetinic acid derivatives, progesterone and progesterone derivatives and their use for the manufacture of a medicament to inhibit 11beta-hydroxysteroid dehydrogenase activity |
| 11/21/2002 | DE10123909A1 Production of ketone compounds useful in pharmacological applications, comprising reacting boronic acid derivatives with carboxylic acid anhydrides in presence of transition metal catalysts, based on palladium, nickel, platinum or copper |
| 11/21/2002 | CA2447232A1 Method for producing ketones from carboxylic acid anhydrides |
| 11/14/2002 | WO2002090375A2 Liver x receptor agonists |
| 11/13/2002 | EP1163257B1 Method for producing 4,4-dimethyl-3beta-hydroxypregna-8,14-diene-21-carboxylic acid esters and intermediate products obtained by said method |
| 11/13/2002 | CN1379674A Ciclesonide contained pharmaceutical composition for application to mucosa |
| 11/12/2002 | US6479681 Bile acid salts |
| 11/07/2002 | WO2002088286A1 Sterol compositions, fat compositions containing the same and foods |
| 11/07/2002 | WO2002088166A1 Preparation of bile acids |
| 11/06/2002 | EP0639970B2 Contraception method using competitive progesterone antagonists and novel compounds useful therein |
| 11/06/2002 | CN1378554A Novel fusidic acid derivatives |
| 10/31/2002 | US20020161040 N-ethyloxycarbonyl-4-aminophenol for example, in depigmentation of skin, hair |
| 10/31/2002 | US20020160990 Esters with a polyunsaturated fatty acid, for example, eicosapentaenoic acid, beta-sitosterol ester; lowering serum cholesterol levels |
| 10/30/2002 | EP1252137A1 Palatable arginine compounds and uses thereof for cardiovascular health |
| 10/30/2002 | CN1377367A Sapogenin derivatives and their use in the treatment of cognitive dysfunction |
| 10/30/2002 | CN1377268A Cell adhesion inhibitors |
| 10/24/2002 | WO2002083147A1 Use of bile acid or bile salt fatty acid conjugates |
| 10/24/2002 | WO2001072315A9 Emulsion containing a plant extract, method for producing said emulsion and for obtaining a plant extract |
| 10/24/2002 | WO2001002421A9 A method for purifying phytosterol concentrates using a pressurized fluid (carbon dioxide) |